ophthalmology

Novartis challenges court ruling allowing use of Avastin in wet AMD

https://pharmaphorum.com/news/novartis-challenges-court-ruling-allowing-use-of-avastin-in-wet-amd/

Ionis and Roche to develop RNAi AMD drug in $760m deal

https://pharmaphorum.com/news/ionis-and-roche-to-develop-rnai-amd-drug-in-760m-deal/

Novartis, Bayer consider appeal as court says Avastin can be used in AMD

https://pharmaphorum.com/news/novartis-bayer-consider-appeal-as-court-says-avastin-can-be-used-in-amd/

Spark/Novartis eye gene therapy nears EU market – but at what price?

https://pharmaphorum.com/news/spark-novartis-eye-gene-therapy-luxturna/

Queen’s University Belfast and Santen to Present Opening Keynote this November

https://pharmaphorum.com/partner-content/queens-university-belfast-and-santen-to-present-opening-keynote-this-november/

The future of ocular gene editing is here

https://pharmaphorum.com/partner-content/the-future-of-ocular-gene-editing-is-here/

Digital health round-up: Hacking medical devices, robot pharmacies and more

https://pharmaphorum.com/views-and-analysis/digital-health-round-up-hacking-medical-devices-robot-pharmacies/

Insightful Developments and an Exclusive Interview from Roche

https://pharmaphorum.com/partner-content/insightful-developments-and-an-exclusive-interview-from-roche/

Astellas buys eye gene therapy biotech Quethera for $109m

https://pharmaphorum.com/news/astellas-expands-ocular-gene-therapy-investment/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search